Phase I/II combined chemoimmunotherapy with carcinoembryonic antigen-derived HLA-A2-restricted CAP-1 peptide and irinotecan, 5-fluorouracil, and leucovorin in patients with primary metastatic colorectal cancer (Q34444838)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I/II combined chemoimmunotherapy with carcinoembryonic antigen-derived HLA-A2-restricted CAP-1 peptide and irinotecan, 5-fluorouracil, and leucovorin in patients with primary metastatic colorectal cancer |
scientific article |
Statements
1 reference
Phase I/II combined chemoimmunotherapy with carcinoembryonic antigen-derived HLA-A2-restricted CAP-1 peptide and irinotecan, 5-fluorouracil, and leucovorin in patients with primary metastatic colorectal cancer (English)
1 reference
Lee M Nadler
1 reference
Martin R Weihrauch
1 reference
Sascha Ansén
1 reference
Elke Jurkiewicz
1 reference
Caroline Geisen
1 reference
Zhinan Xia
1 reference
Karen S Anderson
1 reference
Edith Gracien
1 reference
Manuel Schmidt
1 reference
Burghardt Wittig
1 reference
Volker Diehl
1 reference
Juergen Wolf
1 reference
Heribert Bohlen
1 reference
1 August 2005
1 reference
1 reference
Identifiers
1 reference